Cartalax + TB-500 + BPC-157

Cartalax + TB-500 + BPC-157 is a proprietary three-component research blend combining Cartalax (10 mg — the Khavinson-group Ala-Glu-Asp tripeptide bioregulator), TB-500 (5 mg — synthetic Ac-thymosin β4, a 43-residue peptide) and BPC-157 (5 mg — the GEPPPGKPADDAGLV pentadecapeptide) in a single lyophilized reference matrix. The formulation is characterised by an unusually wide molecular-weight span (333 → 4963 Da) and an asymmetric ~30 : 1 : 3.5 molar loading, making it a compact analytical reference for developing chromatographic and mass-spectrometric methods that need to resolve small bioregulator peptides, mid-size proline-rich peptides and large intrinsically-disordered thymosin fragments in a single run. Supplied as a lyophilized research material for in vitro laboratory use only. Not for human or veterinary use.

Available options

20 mg

Technical information

CAS number

Not applicable(CAS per constituent — Cartalax (none assigned), TB-500 77591-33-4, BPC-157 137525-51-0)

Molecular formula

—

Molecular weight

Cartalax 333.29 g/mol / TB-500 4963.44 g/mol / BPC-157 1419.55 g/mol

Form

White to off-white lyophilized powder

Storage

Store at -20°C, desiccated, sealed, protected from light

For in-vitro laboratory and analytical research only. Not for human or animal consumption. Not for therapeutic, diagnostic, or personal use.